Anemia during pregnancy, particularly iron deficiency anemia (IDA), poses a significant health challenge, with a prevalence rate varying between 6.9% and 28.7% in the United States, influenced by racial, ethnic, and socioeconomic factors. Data from the WIC program indicate that about 10% of participating pregnant women suffer from anemia, classified as a mild to moderate public health risk, especially among Black women and those diagnosed in later pregnancy stages. This situation calls for enhanced public health interventions and strategies.

Severe anemia in pregnancy is linked to increased risks of maternal and fetal issues such as preterm birth and low birth weight, stressing the need for prompt and effective management and prevention. Clinicians are urged to adopt a thorough approach involving detailed medical history, physical exams, and lab tests for accurate diagnosis and treatment, typically with iron supplementation. However, treatment strategies may vary depending on the severity of anemia and individual health needs, underscoring the necessity for tailored medical care to address this widespread condition effectively.

Reference: Waters A. Assessment and management of anemia during pregnancy. Womens Healthcare. 2024;12(1):17-21,34. doi: 10.51256/WHC022417.